Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERATE-A: TMP-301 in Alcohol Use Disorder
NCT06648655Phase 2Terminated
- Sponsor
- Tempero Bio
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TMP-301 in alcohol use disorder (AUD), sponsored by Tempero Bio. Started Nov 2024; status: terminated.
02
Drugs
TMP-301
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06648655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648655.